Photo from wikipedia
Prior randomized controlled trials (RCT) evaluating the optimal antithrombotic therapies for patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) have not been powered to evaluate ischemic outcomes. We… Click to show full abstract
Prior randomized controlled trials (RCT) evaluating the optimal antithrombotic therapies for patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) have not been powered to evaluate ischemic outcomes. We compared double therapy with oral anticoagulation (OAC) and a P2Y12 inhibitor to triple therapy with an OAC + dual antiplatelet therapy in patients with AF requiring PCI.
Keywords:
atrial fibrillation;
fibrillation undergoing;
patients atrial;
percutaneous coronary;
therapy;
undergoing percutaneous
Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!